These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 628007)

  • 41. [4-(0-methyl)-L-threonine] -oxytocin. Synthesis and uterotonic activity.
    Bańkowski K
    Pol J Pharmacol Pharm; 1988; 40(3):331-5. PubMed ID: 2853867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and biological activities of oxytocin and lysine vasopressin analogs containing glutamic acid gamma-hydrazide in position 4.
    Gazis D; Glass J; Schwartz IL; Stavropoulos G; Theodoropoulos D
    Int J Pept Protein Res; 1989 Nov; 34(5):353-7. PubMed ID: 2613436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and biological evaluation of oxytocin analogues containing L-alpha-t-butylglycine [Gly(Bu t)] in positions 8 or 9.
    Fragiadaki M; Magafa V; Slaninová J; Cordopatis P
    Peptides; 2003 Sep; 24(9):1425-31. PubMed ID: 14706558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Secondary structure of the cyclic moiety of the peptide hormone oxytocin and its deamino analog.
    Urry DW; Ohnishi M; Walter R
    Proc Natl Acad Sci U S A; 1970 May; 66(1):111-6. PubMed ID: 5273889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and some biological properties of 1-deamino-4-glu-oxytocin (1-beta-mercaptopropionic acid-4-glutamic acid-oxytocin) and its use in preparing a hormone-agarose complex.
    Ferrier BM; Branda LA
    Can J Biochem; 1975 Jan; 53(1):21-7. PubMed ID: 1120287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxytocin analogues with amide groups substituted by tetrazole groups in position 4, 5 or 9.
    Manturewicz M; Grzonka Z; Borovicková L; Slaninová J
    Acta Biochim Pol; 2007; 54(4):805-11. PubMed ID: 18084651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the importance of the asparagine residue in oxytocin. Synthesis and some pharmacological properties of [1-alpha-mercaptoacetic acid, 5-isoasparagine] oxytocin.
    Roy J; Johnson M; Dubin S; Gazis DC; Schwartz IL
    Int J Pept Protein Res; 1980 Mar; 15(3):279-84. PubMed ID: 6985566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxytocin analogs with oxygen-containing side chains in position 3.
    Gazis D; Schwartz IL; Cordopatis P; Theodoropoulos D
    Int J Pept Protein Res; 1986 Jun; 27(6):679-84. PubMed ID: 3759339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and some pharmacological properties of [8-L-tryptophan]oxytocin.
    Bodanszky M; Tolle JC; Seto J; Sawyer WH
    J Med Chem; 1980 Nov; 23(11):1259-61. PubMed ID: 7452679
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
    Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological activities of [7-(azetidine-2-carboxylic acid)]-oxytocin and -lysine-vasopressin.
    Barber M; Jones JH; Stachulski AV; Bisset GW; Chowdrey HS; Hudson AL
    Int J Pept Protein Res; 1979; 14(3):247-61. PubMed ID: 521209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [5-(N4,N4-Dimethylasparagine),8-lysine]vasopressin: the first 5-position neurohypophyseal hormone analogue to retain to retain significant antidiuretic potency.
    Smith CW; Walter R; Stavropoulos G; Theodoropoulos D
    J Med Chem; 1980 Feb; 23(2):217-9. PubMed ID: 7359538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biofunctional evaluation of a hydrogen bond stabilizing the beta-turn in the acyclic part of oxytocin.
    Roy J; Johnson M; Gazis D; Schwartz IL
    Int J Pept Protein Res; 1980 Jul; 16(1):55-60. PubMed ID: 7192272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxytocin- and vasopressin-binding sites in the rat uterus: competition binding and inhibitory pA2 studies with oxytocin and oxytocin antagonists.
    Chan WY; Cao L; Hill PS; Hruby VJ
    Endocrinology; 1990 Apr; 126(4):2095-101. PubMed ID: 2318158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biofunctional evaluation of two hydrogen bonds stabilizing the beta-turn in the acyclic component of oxytocin.
    Roy U; Gazis D; Schwartz IL; Roy J
    Int J Pept Protein Res; 1983 Oct; 22(4):398-403. PubMed ID: 6654586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluorescent, photoaffinity, and biotinyl analogs of oxytocin.
    Buku A; Yamin N; Gazis D
    Peptides; 1988; 9(4):783-6. PubMed ID: 3226954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemical syntheses and biological studies on dimeric chimeras of oxytocin and the V(2)-antagonist, d(CH(2))(5)[D-Ile(2), Ile(4)]arginine vasopressin.
    Chen L; Golser R; Machová A; Slaninová J; Barany G
    J Med Chem; 1999 Dec; 42(24):5002-9. PubMed ID: 10585209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Some biological properties of an "irreversible" antagonist of neurohypophyseal hormones, deamino-[Phe(4-BrCH2CONH)2]-oxytocin, and its isosteric analogue, deamino-[Phe(4-CH3CH2CONH)2]-oxytocin.
    Pliska V; Marbach P
    Eur J Pharmacol; 1978 Jun; 49(3):213-22. PubMed ID: 658139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.